|
Dr. Berenson featured on ReachMD XM Satellite Radio Channel 157 “Multiple Myeloma: Current Treatment Modalities” Free registration required.
2006 June
LAGlambda-1: a clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myeloma. Read Article
2006 June
Serum pleiotrophin levels are elevated in multiple myeloma patients and correlate with disease status. Read Article
2006 May
Interference with nuclear factor kappa B and c-Jun NH(2)-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis. Read Article
2006 Feb
Phase I/II trial assessing bortezomib and melphalan combination therapy for the treatment of patients with relapsed or refractory multiple myeloma.
Read Article
These articles available on www.pubmed.gov
| 
